Respiratory care startup Telesair raises over $22 million in digital health funding

Telesair, a medical device company that develops hospital-to-home respiratory care products, announced that it has raised $22 million in Series A funding.

The round was led by Pasaca Capital with participation from Honeywell Ventures, ZhenCheng Capital, Shangbay Capital, Device of Tomorrow Capital, Berkeley Catalyst Fund and Ultrastar Ventures LLC.

The investment will serve to commercialize the Bonhawa respiratory humidifier, designed for use in the ICU, and will support the development of a new product that aims to help patients leave the hospital faster and stay home safely.

“Honeywell aligns with Telesair’s mission to improve lives through innovation in digital health,” said Patrick Hogan, managing director of Honeywell Ventures, in a statement. “We are impressed with their mission and technology roadmap, and are excited to collaborate with them in critical areas such as advanced detection and remote patient monitoring using artificial intelligence and machine learning. »

ModifyHealth, which offers meals with medical adjustments and offers virtual support from nutritionists, raised $10 million in a Series B funding round led by RC Capital with participation from existing investor Nashville Capital Network.

The startup works with patients suffering from chronic illnesses such as type 2 diabetes, hypertension, kidney disease, obesity and irritable bowel syndrome. Edit, who raised his The 2020 $2 million Series A plans to use the funds to support its growth and expand operations across the country.

“Diet and lifestyle play a critical role in managing chronic disease and we are just scratching the surface of the impact we can have. RCC is a perfect fit for ModifyHealth and their strategic support, healthcare expertise and shared vision will help us achieve results faster and more broadly,” said GB Pratt, founder and CEO of ModifyHealth, in a statement.

Healthcare cybersecurity software developer Censinet has secured $9 million in a funding round led by the MemorialCare Innovation Fund.

Other participants in the increase include Rex Health Ventures, Ballad Ventures, LRVHealth, HLM Venture Partners, Schooner Capital, Excelerate Health Ventures and Cedars Sinai. Censinet said the round brings its total funding to more than $22 million.

“With breaches on the rise and ransomware now a direct threat to patient safety, the healthcare industry’s need to transform cyber risk management has never been more urgent. Censinet’s unique risk exchange enables providers, payers and providers to collaboratively manage enterprise and third-party risk, continuously improving risk posture in real time and strengthening cybersecurity across all healthcare organizations, said Ed Gaudet, CEO and company founder, in a statement.

Dutch startup Lapsi Health raised $3.7 million in a seed funding round led by Sahir Ali of Modi Ventures.

the company is develop digital biomarkers using auscultatory sounds or internal body sounds from the heart, lungs and abdomen. Lapsi will use the capital to continue to develop its tools, submit to the FDA and expand into the US market.

CARI Health, which is developing a wearable sensor for medication management, has raised $2.3 million in seed funding.

The round was led by the San Diego Angel Conference (SDAC) with participation from NuFund Venture Group, Cove Fund, Chemical Angel Fund, Medical Devices of Tomorrow and angel investors.

The startup is creating a skin sensor that can remotely track medications. If medication levels fall outside established guidelines, patients, families, and providers can receive alerts.

The capital will be used to complete its first human clinical studies, expand its intellectual property portfolio and plan a regulatory filing with the FDA. CARI will initially focus on monitoring medications for opioid use disorder (MOUD).

“We are passionate about the potential to make an impact and build something bigger than ourselves,” Founder and CEO Patrik Schmidle said in a statement. “Portable remote monitoring would change the lives of hundreds of thousands of MOUD patients, who under current standards of care must show up almost daily for clinical visits, especially early in treatment.”

Leave a Comment